Subscribe
shutterstock_1891094320_guteksk7
guteksk7 / Shutterstock.com
23 December 2021Big PharmaAlex Baldwin

Oxfam says Moderna hid vaccine dispute from investors

Oxfam America has filed a complaint with the US Securities and Exchange Commission (SEC) claiming that  Moderna failed to inform investors that it was in a dispute with the  National Institutes of Health over a COVID–19 vaccine patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Moderna in dispute with US govt over COVID-19 vaccine inventors
11 November 2021   Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.
Big Pharma
Dems pressure Biden to share Moderna vaccine tech
14 October 2021   A group of 12 Democratic Party members, including Senator Elizabeth Warren, have co-signed a letter calling for the Biden administration to share Moderna’s vaccine technology.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Americas
Moderna in dispute with US govt over COVID-19 vaccine inventors
11 November 2021   Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.
Big Pharma
Dems pressure Biden to share Moderna vaccine tech
14 October 2021   A group of 12 Democratic Party members, including Senator Elizabeth Warren, have co-signed a letter calling for the Biden administration to share Moderna’s vaccine technology.

More on this story

Americas
Moderna in dispute with US govt over COVID-19 vaccine inventors
11 November 2021   Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.
Big Pharma
Dems pressure Biden to share Moderna vaccine tech
14 October 2021   A group of 12 Democratic Party members, including Senator Elizabeth Warren, have co-signed a letter calling for the Biden administration to share Moderna’s vaccine technology.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB